Panion & Bf Biotech Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 661.56 million compared to TWD 529.37 million a year ago. Net income was TWD 77.97 million compared to TWD 59.87 million a year ago. Basic earnings per share from continuing operations was TWD 0.91 compared to TWD 0.77 a year ago. Diluted earnings per share from continuing operations was TWD 0.91 compared to TWD 0.77 a year ago.
For the nine months, sales was TWD 1,930.92 million compared to TWD 1,436.63 million a year ago. Net income was TWD 278.7 million compared to TWD 109.41 million a year ago. Basic earnings per share from continuing operations was TWD 3.25 compared to TWD 1.42 a year ago. Diluted earnings per share from continuing operations was TWD 3.25 compared to TWD 1.42 a year ago.